S-1 for 6 months + S-1 for 1 year
Phase 3Withdrawn 0 views this week 0 watching💤 Quiet
Interest: 32/100
32
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Gastric Cancer
Conditions
Gastric Cancer
Trial Timeline
Mar 1, 2016 → Mar 1, 2023
NCT ID
NCT02736552About S-1 for 6 months + S-1 for 1 year
S-1 for 6 months + S-1 for 1 year is a phase 3 stage product being developed by Sun Pharmaceutical for Gastric Cancer. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT02736552. Target conditions include Gastric Cancer.
What happened to similar drugs?
5 of 20 similar drugs in Gastric Cancer were approved
Approved (5) Terminated (2) Active (14)
Hype Score Breakdown
Clinical
17
Activity
0
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02736552 | Phase 3 | Withdrawn |
Competing Products
20 competing products in Gastric Cancer